Buscador de publicaciones

Publicaciones

  • Dangouloff T, Burghes A, Tizzano E and Servais L.

    244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10-12, 2019, Hoofdorp, The Netherlands.

    NEUROMUSCULAR DISORDERS . 30(1): 93-103. Nº de citas: 56

    [doi:10.1016/j.nmd.2019.11.002]

  • Serra-Juhe C and Tizzano E.

    Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors.

    EUROPEAN JOURNAL OF HUMAN GENETICS . 27(12): 1774-1782. Nº de citas: 28

    [doi:10.1038/s41431-019-0415-4]

  • Martin-Nalda A, Cueto-González AM, Argudo-Ramírez A, Marin-Soria JL, Martinez-Gallo M, Colobran R, Plaja A, Castells N, Riviere J, Tizzano E and Soler-Palacin P.

    Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years' experience in Catalonia (Spain).

    Molecular genetics & genomic medicine . 7(12): . Nº de citas: 7

    [doi:10.1002/mgg3.1016]

  • Tizzano E.

    Treating neonatal spinal muscular atrophy: A 21st century success story?

    EARLY HUMAN DEVELOPMENT . 138: 104851-104851. Nº de citas: 14

    [doi:10.1016/j.earlhumdev.2019.104851]

  • Mendonça RH, Rocha AJ, Lozano-Arango A, Diaz AB, Castiglioni C, Silva AMS, Reed UC, Kulikowski L, Paramonov I, Cuscó I, Tizzano E and Zanoteli E.

    Severe brain involvement in 5q spinal muscular atrophy type 0.

    ANNALS OF NEUROLOGY . 86(3): 458-462. Nº de citas: 39

    [doi:10.1002/ana.25549]

  • Darras BT, Crawford TO, Finkel RS, Mercuri E, De Vivo DC, Oskoui M, Tizzano E, Ryan MM, Muntoni F, Zhao G, Staropoli J, McCampbell A, Petrillo M, Stebbins C, Fradette S, Farwell W and Sumner CJ.

    Neurofilament as a potential biomarker for spinal muscular atrophy.

    Annals of Clinical and Translational Neurology . 6(5): 932-944. Nº de citas: 160

    [doi:10.1002/acn3.779]

  • Valenzuela I, Segura-Puimedon M, Rodríguez-Santiago B, Fernández-Alvarez P, Vendrell T, Armengol L and Tizzano E.

    Further delineation of the phenotype caused by loss of function mutations in PRMT7.

    EUROPEAN JOURNAL OF MEDICAL GENETICS . 62(3): 182-185. Nº de citas: 13

    [doi:10.1016/j.ejmg.2018.07.007]

  • Estañ MC, Fernández-Núñez E, Zaki MS, Esteban MI, Donkervoort S, Hawkins C, Caparros-Martin JA, Saade D, Hu Y, Bolduc V, Chao KR, Nevado J, Lamuedra A, Largo R, Herrero-Beaumont G, Regadera J, Hernandez-Chico C, Tizzano E, Martinez-Glez V, Carvajal JJ, Zong R, Nelson DL, Otaify GA, Temtamy S, Aglan M, Issa M, Bönnemann CG, Lapunzina P, Yoon G and Ruiz-Perez VL.

    Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy.

    NATURE COMMUNICATIONS . 10(1): 797-797. Nº de citas: 32

    [doi:10.1038/s41467-019-08548-9]

  • Pinto MM, Monges S, Malfatti E, Lubieniecki F, Lornage X, Alias L, Labasse C, Madelaine A, Fardeau M, Laporte J, Tizzano E and Romero NB.

    Sarcomeric disorganization and nemaline bodies in muscle biopsies of patients with EXOSC3-related type 1 pontocerebellar hypoplasia.

    MUSCLE & NERVE . 59(1): 137-141. Nº de citas: 7

    [doi:10.1002/mus.26305]

  • Tizzano E and Zafeiriou D.

    Prenatal aspects in spinal muscular atrophy: From early detection to early presymptomatic intervention.

    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . 22(6): 944-950. Nº de citas: 22

    [doi:10.1016/j.ejpn.2018.08.009]